Which hedge funds own CSTL? CASTLE BIOSCIENCES INC, Q2 2026 13F holders
24 tracked hedge funds disclosed a position in CSTL (CASTLE BIOSCIENCES INC) in their Q2 2026 13F filings, worth $153.6m in total. The largest holder by portfolio weight is RTW Investments, LP at 0.6% of its book. 3 opened a new position this quarter: EntryPoint Capital, LLC, Point72 Asset Management, L.P., Freestone Grove Partners LP. 7 exited: Formula Growth Ltd, Fox Run Management, L.L.C., Gsa Capital Partners LLP.
- 24
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 3
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 7
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $8.7m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $4.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $154m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Formula Growth Ltd | 0.5% | $1.1m |
| Fox Run Management, L.L.C. | 0.1% | $618k |
| Gsa Capital Partners LLP | 0.02% | $300k |
| Graham Capital Management, L.P. | 0.01% | $273k |
| ExodusPoint Capital Management, LP | 0.01% | $801k |
| Magnetar Financial LLC | 0.01% | $573k |
| Brevan Howard Capital Management LP | 0.0% | $456k |
Ownership over time
Who discovered CSTL first? Beta
| Pura Vida Investments, LLC | Q2 2024 | +1.3 pts |
| Parkman Healthcare Partners LLC | Q3 2023 | +1.2 pts |
| Birchview Capital, LP | Q3 2024 | +0.7 pts |
| Soleus Capital Management, L.P. | Q3 2022 | +0.6 pts |
| Summit Partners Public Asset Management, LLC | Q4 2025 | −0.2 pts |
| Greenhouse Funds LLLP | Q2 2022 | −0.3 pts |
| Stonepine Capital Management, LLC | Q2 2022 | −0.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.